Molecular pathways in idiopathic pulmonary fibrosis pathogenesis: Transcending barriers to optimally targeted pharmacotherapies.

Strykowski, Rachel; Adegunsoye, Ayodeji

Strykowski, Rachel; Adegunsoye, Ayodeji.

Afiliação

Strykowski R; Section of Pulmonary & Critical Care, Department of Medicine, The University of Chicago, Chicago, IL, United States. Electronic address: Rachel.Strykowski@uchospitals.edu.
Adegunsoye A; Section of Pulmonary & Critical Care, Department of Medicine, The University of Chicago, Chicago, IL, United States. Electronic address: deji@uchicago.edu.

EBioMedicine ; 67: 103373, 2021 05.

Article em En | MEDLINE | ID: mdl-33965873

Assuntos

Fibrose Pulmonar Idiopática; Humanos; Fibrose Pulmonar Idiopática/tratamento farmacológico; Fibrose Pulmonar Idiopática/etiologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar Idiopática Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Revista: EBioMedicine Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google